PSMA is also selectively upregulated in 90–100% of PCa lesions and it is overexpressed in metastatic, poorly differentiated, hormone-refractory carcinomas as well as in cancerous bone metastases and lymph nodes [9, 10]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.